Tell us about your top U.S. Supreme Court or federal appeals court victory over the past year and how you and your team achieved the win.

Fish won a unanimous Federal Circuit decision in Gilead Sciences, Inc. v. Merck & Co. Inc. in April 2018 affirming the wipe-out of a $200 million jury verdict against our client Gilead after we proved Merck had forfeited its right to assert its hepatitis C drug patents against Gilead because of unclean hands. In July 2018, the Federal Circuit also summarily affirmed Gilead's $14 million in attorneys' fees award. This case was a wild ride from beginning to end, and involved the worst misconduct our team had ever seen. Our all-women oral argument team cemented the victory – after an oral argument that lasted three times longer than the normal appellate argument – with the Federal Circuit's decision noting Merck's litigation misconduct “infected this entire case.”

How did your firm approach appellate success over the past year?